Molecular Variability in Levodopa Absorption and Clinical Implications for the Management of Parkinson’s Disease
Journal of Parkinson’s Disease · 15.10.2024 · 14 (7) · 1353-1368
DOI: 10.3233/jpd-240036 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Parkinson’s Disease, online erschienen am 31.08.2024. Verfasst von Ana Luisa Pedrosa de Menezes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Levodopa, Parkinson Disease, Antiparkinson Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Levodopa is the most widely used medication for the symptomatic treatment of Parkinson’s disease and, despite being an “old” drug, is still considered the gold standard for offering symptomatic relief. The pharmacokinetic and pharmacodynamics of levodopa have been studied extensively. Our review explores the molecular mechanisms that affect the absorption of this drug, focusing on the large intra- and interindividual variability of absorption that is commonly encountered in daily clinical practice, and on the interaction with other medications. In addition, we will explore the clinical implications of levodopa absorption variability and address current and future strategies for researchers and clinicians.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Mayo Clinic, Rochester, MN, USA.
- Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Donders Institute for Brain, Radboud University Medical Center, Cognition and Behaviour, Nijmegen, The Netherlands.
Zitieren
APA
Pedrosa de Menezes, A. L., Bloem, B. R., Beckers, M., Piat, C., Benarroch, E. E., & Savica, R. (2024). Molecular Variability in Levodopa Absorption and Clinical Implications for the Management of Parkinson’s Disease. Journal of Parkinson’s Disease, 14(7), 1353-1368. https://doi.org/10.3233/jpd-240036
Vancouver
Pedrosa de Menezes AL, Bloem BR, Beckers M, Piat C, Benarroch EE, Savica R. Molecular Variability in Levodopa Absorption and Clinical Implications for the Management of Parkinson’s Disease. Journal of Parkinson’s Disease. 2024;14(7):1353-1368. doi:10.3233/jpd-240036
BibTeX
@article{PedrosadeMenezes2024,
author = {Pedrosa de Menezes, Ana Luisa and Bloem, Bastiaan R and Beckers, Milan and Piat, Capucine and Benarroch, Eduardo E and Savica, Rodolfo},
title = {Molecular Variability in Levodopa Absorption and Clinical Implications for the Management of Parkinson’s Disease},
journal = {Journal of Parkinson’s Disease},
year = {2024},
volume = {14},
number = {7},
pages = {1353--1368},
doi = {10.3233/jpd-240036}
}
EUVIMED